Silva Kleiton Augusto Santos, Emter Craig A
Department of Biomedical Sciences, University of Missouri-Columbia, Columbia, Missouri.
JACC Basic Transl Sci. 2020 Aug 24;5(8):840-856. doi: 10.1016/j.jacbts.2020.04.011. eCollection 2020 Aug.
Preclinical large animal models of heart failure (HF) play a critical and expanding role in translating basic science findings to the development and clinical approval of novel therapeutics and devices. The complex combination of cardiovascular events and risk factors leading to HF has proved challenging for the development of new treatments for these patients. This state-of-the-art review presents historical and recent studies in porcine, ovine, and canine models of HF and outlines existing methodologies and physiological phenotypes. The translational importance of large animal studies to clinical success is also highlighted with an overview of recent devices approved by the Food and Drug Administration, together with preclinical HF animal studies used to aid both development and safety and/or efficacy testing. Increasing the use of large animal models of HF holds significant potential for identifying the novel mechanisms underlying the clinical condition and to improving physiological and economical translation of animal research to successfully treat human HF.
心力衰竭(HF)的临床前大型动物模型在将基础科学研究成果转化为新型治疗方法和器械的研发及临床批准方面发挥着关键且不断扩大的作用。导致HF的心血管事件和风险因素的复杂组合已证明对开发针对这些患者的新治疗方法具有挑战性。这篇前沿综述介绍了猪、羊和犬HF模型的历史及近期研究,并概述了现有的方法和生理表型。通过概述美国食品药品监督管理局最近批准的器械以及用于辅助开发和安全性及/或有效性测试的临床前HF动物研究,还强调了大型动物研究对临床成功的转化重要性。增加HF大型动物模型的使用在识别临床病症背后的新机制以及改善动物研究在生理和经济方面向成功治疗人类HF的转化方面具有巨大潜力。